Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

1(33.3%)

Phase 2

1(33.3%)

Phase 4

1(33.3%)

3Total

N/A(1)

Phase 2(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT05128695Unknown

Public Health Consequences of Covid-19

Role: collaborator

NCT02757157Not ApplicableTerminated

Comparison of Walking in Water and on Land in People With Chronic Obstructive Pulmonary Disease (COPD)

Role: collaborator

NCT03275116Phase 4Unknown

The Effect of Twice Daily vs. Once Daily Bronchodilation on Hyperinflation in COPD Patients During 24 Hours.

Role: collaborator

NCT01067248Completed

Chronic Obstructive Pulmonary Disease (COPD) and Osteoporosis

Role: collaborator

NCT00244192Phase 2Completed

Effects of Infliximab (Remicade) on Fat Free Mass in Patients With Moderate to Severe COPD Suffering From Cachexia

Role: lead

All 5 trials loaded